- "
SCYNEXIS Announces Successful Completion of
Phase 1
Trial Evaluating Intravenous (IV)
Formulation of Ibrexafungerp". www.
scynexis.com.
Scynexis inc...
- results, analytics,
chemical registration and
pharmacokinetics data - from
Scynexis. In
October 2012,
Accelrys acquired Aegis Analytical Corp. for $30 million...
-
Sandoz (Novartis)
Scienion Shionogi Soligenix Stryker Sun
Pharmaceuticals Scynexis Taiho Oncology Tara
Innovations Terumo Medical 3D
Biotek The Medicines...
- the
board of
directors for ChemoCentryx,
Immune Design, Metabolex, and
Scynexis. He was a co-founder of
Chiron and
served as the company's
president and...
- July 2011 it was
announced that the IVCC had
signed an
agreement with
Scynexis, Inc., a New
Jersey biotech firm,
under which the
latter would “screen...
-
directors at many
biotech companies,
including Zymogenetics, Chimerix,
Scynexis, and
Immune Design. From 1998 to 2002,
Penhoet was dean of the
School of...
-
represented Eli Lilly, Forendo,
Astellas Pharm,
Acella Pharmaceuticals,
Scynexis,
Myovant Sciences,
Avion Pharmaceuticals, L'Oréal,
Cosmetique Active, Vichy...
-
Pfenex Roche Romark Laboratories, L.C. (former)
Sanofi Pasteur (former)
SCYNEXIS Seqirus (former) Siga Technologies, Inc. Soligenix, Inc. The
Texas A&M...
